Related Experiment Videos
[Cutaneous polyarteritis nodosa following hepatitis B vaccination]
A-M Bourgeais1, M-X Dore, A Croue
1Service de Dermatologie et Vénéréologie, CHU Angers, 49033 Angers Cedex 01.
Annales De Dermatologie Et De Venereologie
|April 3, 2003
Summary
This case study details a rare instance of cutaneous periarteritis nodosa developing one month after hepatitis B vaccination. The condition, characterized by livedo and necrotic vasculitis, showed a prolonged, benign course unresponsive to treatment.
Area of Science:
- Dermatology
- Immunology
- Vaccinology
Background:
- Cutaneous periarteritis nodosa is a rare vasculitis with unknown causes.
- The association between hepatitis B infection and systemic periarteritis nodosa is established.
- Few cases link cutaneous periarteritis nodosa to hepatitis B viral infection.
Observation:
- A 37-year-old woman developed livedo one month post-hepatitis B vaccination.
- Histological examination revealed necrotic vasculitis consistent with periarteritis nodosa.
- The condition presented as a slowly progressing, isolated cutaneous manifestation over seven years.
Findings:
- The patient's cutaneous periarteritis nodosa was diagnosed based on clinical presentation, histology, and prolonged progression.
- Treatment with hydroxychloroquine and colchicine was ineffective.
- This case represents a potential link between hepatitis B vaccination and cutaneous periarteritis nodosa.
Implications:
- While the vaccine's role is unproven, immune complexes involving hepatitis B surface antigen (HBsAg) may be implicated.
- Cutaneous periarteritis nodosa is distinguished from systemic forms by its localized nature and benign, protracted course.
- Further investigation is warranted to understand the physiopathology and potential causal relationship between hepatitis B vaccination and cutaneous vasculitis.